O. Koshelskaya

发表

ACE and AGTR1 Polymorphisms in Pathogenesis of Human Left Ventricular Hypertrophy

M. Golubenko, V. Puzyrev, A. Kucher, 2004, Molecular Biology.

Morphological and functional characteristics of retrosternal adipose tissue and their relation to arterial stiffness parameters in patients after coronary artery bypass grafting

A. Boshchenko, N. Naryzhnaya, S. Andreev, 2020, Bulletin of Siberian Medicine.

Association of decreased glomerular filtration rate with renal hemodynamic disorders and inflammatory biomarkers in patients with medically-controlled hypertension of high cardiovascular risk

I. Kologrivova, O. Zhuravleva, O. Koshelskaya, 2021, Russian Journal of Cardiology.

Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease

I. Kologrivova, I. Vinnitskaya, Suslova Te, 2020, Rational Pharmacotherapy in Cardiology.

Prediction of basal glycaemia dynamics during treatment with 6-month lipid-lowering therapy in patients at high risk of cardiovascular disease

Karpov Rs, E. Kravchenko, O. Zhuravleva, 2017 .

Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity

A. Boshchenko, N. Naryzhnaya, I. Kologrivova, 2021, Biomedicines.

Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis

A. Boshchenko, N. Naryzhnaya, S. Andreev, 2022, Biomedicines.

The level of reactive oxygen species production by adipocytes of epicardial adipose tissue is associated with an increase in postprandial glycemia in patients with severe coronary atherosclerosis

N. Naryzhnaya, S. Andreev, I. Kologrivova, 2021, The Siberian Journal of Clinical and Experimental Medicine.

MRI assessment of the abdominal adipose tissue and the state of the abdominal aorta in patients with coronary artery disease: association with metabolic disorders

I. Kologrivova, V. Ussov, N. Ryumshina, 2021, Bulletin of Siberian Medicine.

Epicardial fat thickness and biomarkers of inflammation in patients with stable coronary artery disease: correlation with the severity of coronary atherosclerosis

R. Karpov, I. Kologrivova, I. Vinnitskaya, 2019, Russian Journal of Cardiology.

[Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2].

R. Karpov, I. Kologrivova, T. Suslova, 2021, Terapevticheskii arkhiv.

Frequency of monocyte subsets is linked to the severity of atherosclerosis in patients with ischemic heart disease: A case-control study

I. Kologrivova, I. Vinnitskaya, T. Suslova, 2020, BioMedicine.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Diane M. Miller, Natalia E. Shilkina, M. C. Cantero, 2018, Lancet.

T-helper-1, T-helper-17, T-regulatory lymphocytes in hypertensive patients with diabetes mellitus type 2 or impaired glucose tolerance: association with clinical and metabolic parameters in a case control study

I. Kologrivova, T. Suslova, O. Koshelskaya, 2016, Translational Medicine Communications.

Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low-Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease

A. Boshchenko, N. Naryzhnaya, I. Kologrivova, 2023, Biomedicines.

Circulating FoxP3+ T-lymphocytes in chronic coronary artery disease: Associations with the severity of atherosclerosis and lipid metabolism

I. Kologrivova, T. Suslova, E. Kravchenko, 2021, The Siberian Journal of Clinical and Experimental Medicine.

Eotaxin and cardio-ankle vascular index in patients with high and very high cardiovascular risk

I. Kologrivova, E. Kravchenko, O. Koshelskaya, 2023, Medical Immunology (Russia).

FOXP3+ T-REGULATORY LYMPHOCYTES IN HYPERTENSIVE PATIENTS

I. Kologrivova, A. Gusakova, T. Suslova, 2019, Journal of Hypertension.